INmune Bio, Inc.

NASDAQ:INMB

5.19 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Operating Activities:
Net Income -9.746-11.025-8.408-8.563-6.501-6.536-5.833-7.725-6.838-6.903-9.671-9.458-6.655-4.556-3.204-4.717-2.108-2.07-2.318-3.067-0.392-1.901-1.88-1.54-6.174-2.846-0.428-0.308-0.1650.031-0.135-0.054
Depreciation & Amortization 00000000000000000000000000000000
Deferred Income Tax 00000000000000000000000000000000
Stock Based Compensation 2.351.7791.8791.8891.8631.7371.7881.9391.8861.5361.5221.6060.7690.8990.7031.0460.6820.6821.1720.9750.9750.9750.9550.985.6062.4610.16300.037000
Change In Working Capital -0.5141.7363.0832.3561.4063.591-1.7182.2720.136-3.554-1.688-0.1240.161-1.4350.109-0.027-0.3920.3540.7120.147-0.658-0.4610.4630.11-0.250.056-0.110.179-0.012-0.127-0.0990
Accounts Receivables -0.723-0.248-0.179-0.2170.1646.251-3.930.5290.588-0.144-0.358-2.027-0.775-0.545000000000000000000
Change In Inventory 006.1980.217-0.164-6.2513.93-0.529-0.58800000000000000000000000
Change In Accounts Payables 0.0711.4144.1821.360.308-3.1291.7421.777-0.864-1.253-0.4181.8610.7880.030.3520.3520.050.3220.193-0.0090.027-0.3430.6120.016-0.001-0.1130.14800000
Other Working Capital 0.1380.57-7.1180.9961.0986.72-3.460.4951-2.301-1.27-1.985-0.627-1.465-0.243-0.379-0.4420.0320.520.155-0.686-0.118-0.150.094-0.2490.169-0.2580.179-0.012-0.127-0.0990
Other Non Cash Items 3.0260.6470.0450.0540.0580.0670.0680.1470.0570.0560.0570.0530.0161.4140.3530.3510.0480.3230.193-0.009-1.542-0.0430.6120.0160.005-0.1130.148-0.0260.053-0.047-0.0140.054
Operating Cash Flow -7.886-7.476-3.401-4.264-3.174-1.141-5.695-3.367-4.759-8.865-9.78-7.923-5.709-5.092-2.393-3.698-1.818-1.035-0.433-1.946-1.618-1.388-0.462-0.45-0.818-0.329-0.375-0.155-0.088-0.144-0.2480
Investing Activities:
Investments In Property Plant And Equipment 000000000000-150000000000000000000
Acquisitions Net 00000000000000000000000000000000
Purchases Of Investments 00000000000000000000000000000000
Sales Maturities Of Investments 00000000000000000000000000000000
Other Investing Activites 002.5510000000-150-150000000000000-0.100000
Investing Cash Flow 002.551-2.551000.6990-0.6990-150-150-23,871.885000-12,196.812000-899.1000-0.100000
Financing Activities:
Debt Repayment -2.5-2.5-2.5-2.500000000-14.9510000000000000000000
Common Stock Issued 15.4970-0.7750.77500-0.699000.729-80.25352.942028.464-24.90823.240.6641.003-12.20904.9587.251-0.9000.9000000
Common Stock Repurchased 000000000000001.01200-1.01200000000000000
Dividends Paid 00000000000000000000000000000000
Other Financing Activities 15.497-2.55.729-1.725000000.72980.25352.94214.9510.01823,895.78123.240.6641.00312,209.02104.9587.251900000.900.031.6550.3710.10
Financing Cash Flow 12.997-2.5-2.5-1.72500-0.699000.729052.94214.95128.46423,871.88523.240.664-0.00912,196.81204.9587.251899.1000.900.031.6550.3710.10
Other Information:
Effect Of Forex Changes On Cash -0.0440.13-0.064-0.023-0.004-0.0090.443-0.441-0.7570.0550.119-0.068-0.0620.0010.048-0.0480.039-0.0210.046-0.036-0.025-0.001-0.002-0.008-0.030.0140.0030.0160.0120.004-0.0060
Net Change In Cash 5.067-9.846-5.965-6.012-3.178-1.15-5.252-3.808-5.516-8.081-9.66144.951-5.8223.373-2.34419.495-1.114-1.065-0.387-1.9813.3155.863-0.465-0.458-0.8480.586-0.473-0.1091.5790.231-0.1540
Cash At End Of Period 31.06926.00235.84841.81347.82551.00352.15357.40561.21366.72974.8184.47139.5245.3421.96724.3114.8175.9316.9967.3839.3646.0490.1860.6511.1081.9561.3711.8431.9520.3730.1420